ID: ALA3409526

Max Phase: Preclinical

Molecular Formula: C22H34Li2N3O7P

Molecular Weight: 485.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NP(=O)([O-])CNC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)(C)C)C(=O)[O-].[Li+].[Li+]

Standard InChI:  InChI=1S/C22H36N3O7P.2Li/c1-15(2)11-17(19(26)24-18(20(27)28)12-22(3,4)5)25-33(30,31)14-23-21(29)32-13-16-9-7-6-8-10-16;;/h6-10,15,17-18H,11-14H2,1-5H3,(H,23,29)(H,24,26)(H,27,28)(H2,25,30,31);;/q;2*+1/p-2/t17-,18-;;/m0../s1

Standard InChI Key:  LPWZBBGQRBOMNK-MPGISEFESA-L

Associated Targets(non-human)

Thermolysin 425 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 485.52Molecular Weight (Monoisotopic): 485.2291AlogP: 3.07#Rotatable Bonds: 12
Polar Surface Area: 154.06Molecular Species: ACIDHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.03CX Basic pKa: CX LogP: 2.74CX LogD: -2.52
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: 0.03

References

1. Nasief NN, Hangauer D..  (2015)  Additivity or cooperativity: which model can predict the influence of simultaneous incorporation of two or more functionalities in a ligand molecule?,  90  [PMID:25559080] [10.1016/j.ejmech.2014.11.056]

Source